4.7 Article

Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand

期刊

BIOCHEMICAL PHARMACOLOGY
卷 78, 期 4, 页码 365-373

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2009.04.027

关键词

Cytotoxic activity; Fluorescence microscopy; Nucleobases; Platinum resistance; Glutathione

资金

  1. Council for Chemical Sciences of The Netherlands Organization for Scientific Research (CW-NWO)
  2. COST Actions [D39/0006/62, D39/0005/11]

向作者/读者索取更多资源

A new fluorescent platinum(II) compound containing the N,N'-bis-(anthracen-9-ylmethyl)propane-1,3-diamine as a carrier ligand has been designed, synthesized and characterized. High cytotoxic activity of cis-[Pt(bapda)Cl-2] is observed in A2780 and A2780R cells (human ovarian carcinoma sensitive and cisplatin-resistant, respectively). Nevertheless, cross-resistance to platinum from cis-[Pt(bapda)Cl-2] in the A2780R cells was found. To study the role of GSH towards inactivation of cis-[Pt(bapda)Cl-2], GSH-depleted and non-depleted A2780R cells were used in several in vitro studies. The results suggest that cis[Pt(bapda)Cl-2] is not susceptible to the inactivation by GSH. Cellular processing of bapda and cis-[Pt(bapda)Cl-2] was followed using fluorescence microscopy in the A2780, the A2780R and GSH-depleted A2780R cells. Interestingly, differences in the cellular processing followed by fluorescence microscopy between normal and GSH-depleted A2780R cells have been observed for the carrier ligand. Sequestration of these compounds in acidic lysosomes is visible after incubation in most cases, and no fluorescence was observed in the nucleus. Interaction of cis-[Pt(bapda)Cl-2] with calf thymus DNA strongly suggests that the this new platinum(II) compound intercalates between the DNA base pairs. Additionally, the reaction of cis-[Pt(bapda)Cl-2] with 9-ethylguanine appears to be very slow, as studied by H-1 and Pt-195 NMR spectroscopy. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Chemistry, Inorganic & Nuclear

Metal interactions with nucleic acids

Michael J. Hannon, Jan Reedijk

DALTON TRANSACTIONS (2015)

Article Biochemistry & Molecular Biology

2,6-Bis(2,6-diethylphenyliminomethyl)pyridine coordination compounds with cobalt(II), nickel(II), copper(II), and zinc(II): synthesis, spectroscopic characterization, X-ray study and in vitro cytotoxicity

Pablo Martinez-Bulit, Ariadna Garza-Ortiz, Edgar Mijangos, Lidia Barron-Sosa, Francisco Sanchez-Bartez, Isabel Gracia-Mora, Angelina Flores-Parra, Rosalinda Contreras, Jan Reedijk, Norah Barba-Behrens

JOURNAL OF INORGANIC BIOCHEMISTRY (2015)

Article Chemistry, Inorganic & Nuclear

Synthesis, structure and spectroscopic properties of bis(triphenylphosphane)iminium (chlorido)(cyanido) argentates(I)

Mohammed Jaafar, Xue Liu, Fabian Dielmann, F. Ekkehardt Hahn, Khalid Al-Farhan, Ali Alsalme, Jan Reedijk

INORGANICA CHIMICA ACTA (2016)

Article Chemistry, Inorganic & Nuclear

Metal-ion nucleic-acid interactions: A personal account

Jan Reedijk

INORGANICA CHIMICA ACTA (2016)

Article Biochemistry & Molecular Biology

Transition-metal norharmane compounds as possible cytotoxic agents: New insights based on a coordination chemistry perspective

Rais Ahmad Khan, Andreia de Almeida, Khalid Al-Farhan, Ali Alsalme, Angela Casini, Mohamed Ghazzali, Jan Reedijk

JOURNAL OF INORGANIC BIOCHEMISTRY (2016)

Article Chemistry, Inorganic & Nuclear

Tetrahedrally coordinated luminescent copper(I) compounds containing halide, phosphane and norharmane ligands

Rais Ahmad Khan, Fabian Dielmann, Xue Liu, F. Ekkehardt Hahn, Khalid Al-Farhan, Ali Alsalme, Jan Reedijk

POLYHEDRON (2016)

Article Chemistry, Inorganic & Nuclear

An unusual Cu(II) complex of a Schiff-base ligand of 3-aminoquinoline with a hydronated pyridine unit: Synthesis, characterizations, and computational studies

Sanjit Nayak, Andrej Pevec, Colin C. Seaton, Patrick Gamez, Jan Reedijk

POLYHEDRON (2016)

Article Chemistry, Multidisciplinary

Names and symbols of the elements with atomic numbers 113, 115, 117 and 118 (IUPAC Recommendations 2016)

Lars Ohrstrom, Jan Reedijk

PURE AND APPLIED CHEMISTRY (2016)

Article Chemistry, Inorganic & Nuclear

The non-coordinating anion 1,1,3,3-tetracyano-2-propoxy-propenide as an anion-π donor in cis-diaquabis(2,2′-dipyridylamine)zinc and its cadmium analog: Luminescence properties, Hirshfeld analysis and central-atom induced polymorphism

Fouzia Lehchili, Fatima Setifi, Xue Liu, Anahid Saneei, Monika Kucerakova, Zouaoui Setifi, Michal Dusek, Morgane Poupon, Mehrdad Pourayoubi, Jan Reedijk

POLYHEDRON (2017)

Article Chemistry, Inorganic & Nuclear

Synthesis, structure and characterisation of (μ-aqua)(diaqua) (μ3-benzene-dicarboxylate-κO1,O2)strontium(II) coordination polymer

Mohamed Ghazzali, Miftahul Khair, Khalid Al-Farhan, Jan Reedijk

INORGANICA CHIMICA ACTA (2014)

Article Biochemistry & Molecular Biology

Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands

Ariadna Garza-Ortiz, Palanisamy Uma Maheswari, Martin Lutz, Maxime A. Siegler, Jan Reedijk

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2014)

Article Chemistry, Inorganic & Nuclear

Synthesis, structure and magnetic properties of an unusual oligonuclear iron(III)-cobalt(III) compound with oxido-, sulfato- and cyanido-bridging ligands

Fatima Setifi, Zouaoui Setifi, Piotr Konieczny, Christopher Glidewell, Samia Benmansour, Carlos J. Gomez-Garcia, Fernande Grandjean, Gary J. Long, Robert Pelka, Jan Reedijk

POLYHEDRON (2019)

Article Pharmacology & Pharmacy

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci

Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Cardiac human bitter taste receptors contain naturally occurring variants that alter function

Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas

Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma

Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li

Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.

BIOCHEMICAL PHARMACOLOGY (2024)

Review Pharmacology & Pharmacy

Ferroptosis resistance in cancer: recent advances and future perspectives

Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang

Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.

BIOCHEMICAL PHARMACOLOGY (2024)